Structure Therapeutics Inc.(NASDAQ:GPCR) 
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 r...
Website: https://structuretx.com
Founded: 2016
IPO Price: $15 (Feb 03, 2023)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 15.73
H 15.95
L 14.88
C 15.12
V 927,922
10EMA 15.12
20EMA 15.12
60EMA 15.12
120EMA 15.12
250EMA 15.12